Biological basis for cerebral dysfunction in schizophrenia in contrast with Alzheimer's disease
Author
dc.contributor.author
Kuljiš, Rodrigo O.
Author
dc.contributor.author
Colom, Luis V.
Author
dc.contributor.author
Rojo, Leonel E.
Admission date
dc.date.accessioned
2019-03-15T16:06:03Z
Available date
dc.date.available
2019-03-15T16:06:03Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
Frontiers in Psychiatry, February 2014 | Volume 4 | Article 119
Identifier
dc.identifier.issn
16640640
Identifier
dc.identifier.other
10.3389/fpsyt.2014.00119
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/166105
Abstract
dc.description.abstract
Schizophrenia and Alzheimer’s disease are two disorders that, while conceptualized as
pathophysiologically and clinically distinct, cause substantial cognitive and behavioral
impairment worldwide, and target apparently similar – or nearby – circuitry in regions such
as the temporal and frontal lobes.We review the salient differences and similarities from
selected historical, nosological, and putative mechanistic viewpoints, as a means to help
both clinicians and researchers gain a better insight into these intriguing disorders, for
which over a century of research and decades of translational development was needed
to begin yielding treatments that are objectively effective, but still very far from entirely
satisfactory. Ongoing comparison and “cross-pollination” among these approaches to disorders
that produce similar deficits is likely to continue improving both our insight into the
mechanisms at play, and the development of biotechnological approaches to tackle both
conditions – and related disorders – more rapidly and efficaciously.